Tower Research Capital (TRC)’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Buy |
8,419
+7,434
| +755% | +$323K | 0.01% | 1247 |
|
|
2025
Q1 | $36.8K | Sell |
985
-5,302
| -84% | -$198K | ﹤0.01% | 2453 |
|
|
2024
Q4 | $285K | Buy |
6,287
+4,910
| +357% | +$222K | 0.01% | 1447 |
|
|
2024
Q3 | $80.9K | Sell |
1,377
-4,654
| -77% | -$273K | ﹤0.01% | 2392 |
|
|
2024
Q2 | $237K | Buy |
6,031
+5,775
| +2,256% | +$227K | ﹤0.01% | 1933 |
|
|
2024
Q1 | $17K | Sell |
256
-7,570
| -97% | -$503K | ﹤0.01% | 3142 |
|
|
2023
Q4 | $219K | Buy |
7,826
+7,361
| +1,583% | +$206K | ﹤0.01% | 2028 |
|
|
2023
Q3 | $9.9K | Buy |
+465
| New | +$9.9K | ﹤0.01% | 4168 |
|